Tag Archives: CRME

Best Performing Stocks To Own Right Now

Source: ThinkstockDecember 20, 2017: The S&P 500 closed relatively flat at 2,679.28. The DJIA closed flat at 24,726.65. Separately, the Nasdaq was flat at 6,960.96.

Wednesday again started out as a good day for the markets, but the exchanges couldnt make up their minds and ended up relatively flat for the day. While Tuesday was a small step back, Wednesday was more of a sidestep than....More>>>

Top 5 High Tech Stocks For 2018

QUALCOMM, Inc. stock has almost fallen to its lowest levels in 2017. Should you buy QCOM stock now?

Shares of San Diego, California-based QUALCOMM, Inc. (NASDAQ:QCOM)plunged further, losing more than 3.5% in yesterday’s trade. QCOM stock is now near its lowest levels since the post-earnings sell off. QCOM stock dipped on account of the smartphone chipmaker losing an arbitration....More>>>

Top 5 High Tech Stocks To Buy Right Now

President, CEO & Chairman of Amarillo Biosciences Inc (AMAR) Stephen T Chen bought 1,032,000 shares of AMAR on 03/09/2018 at an average price of $0.19 a share. The total cost of this purchase was $196,080.

Amarillo Biosciences Inc is a specialty biopharmaceutical company. The Company is engaged in developing biologics for the treatment of human and animal diseases including influenza,....More>>>

Top 5 Safest Stocks To Own Right Now

The stock market’s relentless march upward has pushed the prices of many companies higher. As investors bid up good and bad businesses alike, it can be hard to discern which companies are the best for long-term investors.

That’s especially true in the world of dividend stocks, where income-starved investors face greater temptation by the day to reach for high dividend stocks that....More>>>

Top Financial Stocks To Own Right Now

15 of the Best Investing Quotes

Biggest Crash Ever Is (Probably) Coming by 2020: Harry Dent

When the IRS Wants Your Life Insurance Policy

Having come of age during the 2008 recession, millennials continue to pursue financial independence and self-sufficiency, according to a Merrill Edge Report released Friday.

Two-thirds of millennials in a survey said they would be able....More>>>

Hot Medical Stocks To Watch For 2018

Medtronic (MDT) is higher Monday, helped by a bullish note from SunTrust Robinson Humphrey.

Medtronic Micra pacemaker Medtronic/Associated Press

Analyst Bruce Nudell and his team intitiated coverage of the stock with a Buy rating and $93 price target. Nudell writes that he likes Medtronics leadership position across major markets, and he believes it can sustain mid-single digit revenue....More>>>

Best Stocks To Invest In 2018

5 Uses for Life Insurance That Most People Haven’t Thought Of

Bernie Swain: Keys to Great Speeches and How Not to Bore Clients

10 Dumbest States for Financial Literacy: 2017

I can’t tell you how many times an owner-advisor client has come to me about an employee who is “not working out,” and most of the time they have already decided the employee just....More>>>

Top 5 Medical Stocks To Watch For 2018

Berkshire Hathaway Chairman and CEO Warren Buffett, right, speaks to Microsoft co-founder and director at Berkshire Hathaway, Bill Gates, as they appear to speak on the Fox Business Network with Liz Claman, in Omaha, Neb., Monday, May 8, 2017. (AP Photo/Nati Harnik)

Just one day after the House of Representatives voted 217-213 to repeal and replace Obamacare, Berkshire Hathaway CEO Warren....More>>>

Top 10 Heal Care Stocks For 2018

 Our colleague Ben Morris has been keeping a close eye on gold.   Back in April, he noted that gold was close to breaking out of a multiyear chart pattern that could send prices much higher. But it wasn't yet official, so Ben recommended being patient and waiting for confirmation before getting too bullish on gold and precious metals.   That was good advice – gold reversed....More>>>

penney stocks

Target Price and Rationale

Target price of $22. Medpace’s (NASDAQ:MEDP) revenue will be flat in 2017 driven by its largest customer (10% of revenues) pulling back spending. This revenue will not be made up by other customers as the funding environment for small biotech is challenged. A bloated cost structure will reduce EBITDA margins due to lower cost absorption. A 10X EBITDA multiple....More>>>